## **Core Concept**
Post-transplant lymphoproliferative disorders (PTLD) are a well-recognized complication of solid organ transplantation and hematopoietic stem cell transplantation. These disorders are often associated with Epstein-Barr virus (EBV) infection, which is a type of herpesvirus. The immune suppression required for transplantation increases the risk of EBV reactivation and subsequent lymphoproliferation.

## **Why the Correct Answer is Right**
The correct answer, **Epstein-Barr Virus (EBV)**, is right because EBV is strongly associated with post-transplant lymphoproliferative disorders (PTLD), particularly in the early period following transplantation. EBV-negative PTLD cases also occur but are less common. The virus infects B lymphocytes, and under normal circumstances, the immune system controls the infection. However, in the immunosuppressed state of transplant recipients, EBV-infected B cells can proliferate uncontrollably, leading to lymphoproliferative disorders.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain bacteria can cause infections in transplant patients, they are not specifically associated with post-transplant lymphomas.
- **Option B:** Other viruses might cause infections in immunocompromised patients, but they are not primarily linked to post-transplant lymphoproliferative disorders.
- **Option D:** Although other viruses and organisms can cause complications in transplant patients, they are not the most common cause of post-transplant lymphoma.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **EBV-negative PTLD tends to occur later than EBV-positive PTLD and often has a worse prognosis**. Monitoring EBV levels post-transplant can help in early detection and management of PTLD.

## **Correct Answer:** . Epstein-Barr Virus (EBV)